Earlier this year, DexCom and Tandem Diabetes teamed up to develop a device that hopes to snag a big market share in the diabetes game: a combination continuous glucose monitor and insulin pump. Using Tandem's T:Slim touch-screen insulin pump as a platform, DexCom will bring its CGM knowhow to develop an all-in-one monitor-and-pump combo. And the benefits could be huge. There's just one combination device already on the market (Medtronic's ($MDT) Paradigm), but T:Slim is the world's smallest insulin pump and the only one with touch-screen controls. If DexCom and Tandem can keep the tech small and navigate the 510(k) process, their combination platform could be a hit in the diabetes world.
5. All-in-one CGM and insulin pump from DexCom and Tandem Diabetes
Read more on